Harvard Business Review November 1, 2019
Until the 1990’s, patients with cancer requiring chemotherapy typically had to be admitted to the hospital to receive treatment. This inpatient care was stressful for patients and expensive. Since then, thanks to improvements in chemotherapy administration and symptom management, most treatment has moved from the inpatient setting to outpatient clinics, which prove more patient-centered and able to provide high quality care at lower cost. Today, aided by ongoing advances in treatment and monitoring technologies, cancer care is poised to make another transition: from the clinic into patients’ homes.
In October 2018, Memorial Sloan Kettering Cancer Center (MSK) launched a pilot program called InSight Care which enables seamless connection with its patients wherever they are, whenever they are in need. This...
Today's Sponsors
Today's Sponsor